Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find Thip Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Thip Hydrochloride
Also known as: Thip hydrochloride, 85118-33-8, Gaboxadol (hydrochloride), Gaboxadol hcl, 478rvh3tvd, 85118-33-8 (hcl)
Molecular Formula
C6H9ClN2O2
Molecular Weight
176.60  g/mol
InChI Key
ZDZDSZQYRBZPNN-UHFFFAOYSA-N
FDA UNII
478RVH3TVD

1 2D Structure

Thip Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one;hydrochloride
2.1.2 InChI
InChI=1S/C6H8N2O2.ClH/c9-6-4-1-2-7-3-5(4)10-8-6;/h7H,1-3H2,(H,8,9);1H
2.1.3 InChI Key
ZDZDSZQYRBZPNN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CNCC2=C1C(=O)NO2.Cl
2.2 Other Identifiers
2.2.1 UNII
478RVH3TVD
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Thip Hydrochloride

2. 85118-33-8

3. Gaboxadol (hydrochloride)

4. Gaboxadol Hcl

5. 478rvh3tvd

6. 85118-33-8 (hcl)

7. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol Hydrochloride

8. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3(2h)-one Monohydrochloride

9. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2h)-one Hydrochloride

10. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2h)-one Monohydrochloride

11. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol Hcl, Gaboxadol-hcl

12. Lu 02-030 (hydrochloride); Thip (hydrochloride)

13. Sr-01000075651

14. Unii-478rvh3tvd

15. Einecs 285-687-7

16. Thip Hcl

17. Thip (hydrochloride)

18. (thip)

19. Mls002154080

20. Spectrum1503648

21. Lu 02-030 (hydrochloride)

22. Chembl1255746

23. Dtxsid90234251

24. Hms1571c05

25. Pharmakon1600-01503648

26. Bcp16610

27. Gaboxadol Hydrochloride [mi]

28. Tox21_501233

29. Ccg-39368

30. Mfcd00055180

31. Nsc759585

32. Akos024015212

33. Lp01233

34. Ncgc00094475-01

35. Ncgc00094475-02

36. Ncgc00094475-03

37. Ncgc00094475-04

38. Ncgc00261918-01

39. As-53745

40. Bp-12453

41. Hy-10233

42. Smr000875361

43. J Med Chem 26: 895 (1983)

44. B6460

45. Cs-0002508

46. Eu-0101233

47. G0405

48. T-101

49. P17040

50. Gaboxadol Hydrochloride, Solid, >=98% (hplc)

51. Sr-01000075651-1

52. Sr-01000075651-3

53. Sr-01000075651-6

54. Sr-01000075651-7

55. Q27259031

56. 9-oxa-3,8-diazabicyclo[4.3.0]non-10-en-7-one Hcl

57. 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2h)-onehydrochloride

58. 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one;hydrochloride

59. Isoxazolo(5,4-c)pyridin-3(2h)-one, 4,5,6,7-tetrahydro-, Hydrochloride (1:1)

60. Isoxazolo(5,4-c)pyridin-3(2h)-one, 4,5,6,7-tetrahydro-, Monohydrochloride

2.4 Create Date
2006-03-07
3 Chemical and Physical Properties
Molecular Weight 176.60 g/mol
Molecular Formula C6H9ClN2O2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass176.0352552 g/mol
Monoisotopic Mass176.0352552 g/mol
Topological Polar Surface Area50.4 Ų
Heavy Atom Count11
Formal Charge0
Complexity210
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY